However, alteration of the Wnt or p53 pathway is not sufficient for HCC development, as the activation of these pathways via altered p53, adenomatous polyposis coli, or β-catenin gene expression has also been observed in benign liver neoplasms [93] and non-tumour tissue surrounding HCC tumours [94,95]. Here, APC is linked to hepatocellular carcinoma.